Clinical trial Recruiting at 2 sites Interventional Ages 22 to 75

Robotically implanted brain-computer interface for patients with severe paralysis

Official title: PRIME: An Early Feasibility Study of a Precise Robotically Implanted Brain-Computer Interface for the Control of External Devices

Run by Neuralink Corp · NCT06429735 · Data updated 2026-11-12

This study is testing a new brain implant that uses a robot to help people with severe paralysis communicate and control devices better.

Quick facts

Study typeInterventional
Ages22 Years to 75 Years
SexAll
Enrollment15 (estimated)
SponsorNeuralink Corp
Industry-sponsored
Locations2 sites (Phoenix, Arizona and 1 other locations)
StatusRecruiting
StartedJanuary 9, 2024
Main results expectedJune 2026
Study endsJanuary 2031
Registry record updatedJanuary 9, 2026
Trial IDNCT06429735 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are individuals with severe quadriplegia or tetraparesis due to spinal cord injury or ALS, who have had no improvement for at least one year.

Probably not a fit

Patients with moderate to high risk for serious perioperative adverse events or those with active implanted devices may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The PRIME Study is an early feasibility assessment aimed at evaluating the safety and functionality of the Neuralink N1 Implant and R1 Robot in individuals suffering from severe quadriplegia or tetraparesis due to spinal cord injury or ALS. This innovative approach involves a wireless, rechargeable implant that connects to electrode threads inserted into the brain by a robotic device. The study seeks to determine how effectively this technology can restore communication and control for patients with significant motor impairments.

Why it matters

Potential benefit: If successful, this technology could significantly enhance the quality of life for patients with severe paralysis by enabling them to control devices and communicate more effectively.

How similar studies have gone: While this approach is novel, similar studies involving brain-computer interfaces have shown promise in preliminary phases.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Severe quadriplegia (tetraplegia) due to spinal cord injury or amyotrophic lateral sclerosis (ALS) for at least 1 year without improvement, where quadriplegia is defined as having very limited or no hand, wrist, and arm movement and all levels below
* Life expectancy ≥ 12 months.
* Ability to communicate in English
* Presence of a stable caregiver

Exclusion Criteria

* Moderate to high risk for serious perioperative adverse events
* Active implanted devices
* Morbid obesity (Body Mass Index \> 40)
* History of poorly controlled seizures or epilepsy
* History of poorly controlled diabetes
* Requires magnetic resonance imaging (MRI) for any ongoing medical conditions
* Acquired or hereditary immunosuppression
* Use of smoking tobacco or other tobacco products
* Psychiatric or psychological disorder
* Brain MRI demonstrating hemorrhage, tumor, distorted or adverse anatomy.
* Any condition which, in the opinion of the Investigator, would compromise your ability to safely participate in the study or undergo the implantation procedure

Where it's running

  • Barrow Neurological Institute
    Phoenix, Arizona, United States
    Recruiting
  • University of Miami
    Miami, Florida, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.